Benlysta
List of products in the National Drug Code with proprietary name benlysta. This medication is used to treat a certain type of lupus, systemic lupus erythematosus, in patients who are receiving other lupus medicines. It works by binding to a protein (found in high levels in patients with active lupus) in the blood and limiting the activity of the protein. It helps decrease the symptoms of lupus. Belimumab is a type of medication called a monoclonal antibody.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
49401-088 | Benlysta | Belimumab | Solution | Subcutaneous | Glaxosmithkline Llc | Human Prescription Drug |
49401-101 | Benlysta | Belimumab | Injection, Powder, Lyophilized, For Solution | Intravenous | Glaxosmithkline Llc | Human Prescription Drug |
49401-102 | Benlysta | Belimumab | Injection, Powder, Lyophilized, For Solution | Intravenous | Glaxosmithkline Llc | Human Prescription Drug |